Home
Knowledge Hub

Knowledge Hub

The added value of a platform approach: pen injector case study

05/06/2021

Nemera is developing its pen injector platform and tailor to meet customer needs. Radosław Romańczuk, MD, Pen Platform Business Development Director; Severine Duband, Category Director, Devices; and ...

The pivotal role played by device developers to improve patient eye care

05/06/2021

Novelia, our preservative-free multidose eye dropper, that addresses the challenges of patients suffering from glaucoma & dry eye diseases.

The right route to take: the smart device that can help manage drug overdosing

05/06/2021

At Nemera, we strive to offer solutions to prevent overdosing of potent drugs.

The untold story of Nemera’s inhalation franchise

05/06/2021

The untold story of Nemera’s inhalation franchise Introduction and disease overview: Imagine the sheer joy and excitement of a child running towards an ice cream truck on a hot ...

Press Article

Holistic device selection and user-experience innovation to drive differenciation

28/05/2021

Considerations for device selection in parenteral applications. Mark Tunkel, Global Category Director, Services at Nemera, looks at the challenges involved in the selection of drug devices for combination products and...

Thought-leadership

Nemera – an integrated CDMO and Own-IP player

04/05/2021

In this report, Alira Health in partnership with MassMEDIC analyzes the rapidly evolving DDD landscape and how industry leaders like Nemera strive to enhance the end-to-end services offering by integrating...